MiRNA Scientific is a precision healthcare company committed to improving public health by transforming cancer management globally. The company’s proprietary miR Disease Management Platform® was developed to revolutionize the standard of value-based care for cancers and initially focuses on urological cancers

The initial test delivered by the miR Disease Management Platform® is the miR Sentinel™ Prostate Cancer Test, the first and only non-invasive liquid biopsy urine test that accurately detects, classifies and can monitor prostate cancer at the molecular level.

MiRNA Scientific, Inc.

Org chart

Teams

Offices